Skip to main content
. 2020 Jun 22;5(6):632–644. doi: 10.1016/j.jacbts.2020.02.004

Figure 1.

Figure 1

Possible Mechanisms by Which SGLT2 Inhibitors Decrease the Severity of Heart Failure

Improved cardiac energetics with SGLT2 inhibition. NLRP3 = nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3; SGLT2 = sodium glucose co-transporter 2.